SynthesisBMC cancer2022

Additional capecitabine use in early-stage triple negative breast cancer patients receiving standard chemotherapy: a new era? A meta-analysis of randomized controlled trials.

Feng Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.